Our Vision and Priorities

The purpose of Imperial College AHSC is to align the research, education and clinical care missions of the partners and accelerate the translation of research into better patient outcomes and population health.

The AHSC’s vision is to reduce the burden of disease and improve human health by:

  • Preventing disease wherever possible,
  • Where ill health cannot be prevented, detecting it earlier, and
  • For all diagnosed disease, developing better disease treatments.

The AHSC forward plan unites common priorities in the partner institutions and aligns with local and national health goals.

Imperial College AHSC key facts and figures infographic, text is accompanied by blue drawn images such as a microscope, rosette, map the pipette. The text reads: Anchored in Northwest London serving a population of 2.7 million people from more than 200 ethnicities. Imperial is a world-leading university for STEMB. Ranked number 1 in Europe (QS World University Rankings 2026), UK's leading institutions for health research - Imperial and ICR are the top UK universities for world-leading research (2021 Research Excellent Framework)
The Royal Marsden and the ICR are in the Top 5 cancer centres globally for research, includes the largest hospital group in England the Northwest London Acute Provide Collaborative. Brings together more than 42,000 academics, NHS clinicians and students working across 9 clinical academic campuses to drive forward the translation of discovery science into health improvement. 3 life science campuses Imperial White City and Paddington Life Sciences as part of West Tech London and the London Cancer Hub